Cargando…

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series

BACKGROUND: Antineutrophil cytoplasmic antibody associated vasculitis (AAV) is a group of diseases associated in most cases with the presence of anti-neutrophil cytoplasmic antibodies (ANCAs). Rituximab- based remission induction has been proven effective in ANCA associated vasculitis but scarce dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caroti, L., Cirami, C. L., Di Maria, L., Larti, A., Carta, P., Dervishi, E., Farsetti, S., Tsalouchos, A., Novelli, L., Minetti, E. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515642/ https://www.ncbi.nlm.nih.gov/pubmed/31088509 http://dx.doi.org/10.1186/s12882-019-1350-x

Ejemplares similares

POS-851 MPO-ANCA ASSOCIATED VASCULITIS AFTER COVID-19
por: GARCIA-VEGA, A., et al.
Publicado: (2022)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis
por: Pacheco, Mariana, et al.
Publicado: (2021)

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2020)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
por: Eindhoven, Stefanie, et al.
Publicado: (2017)

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
por: Voorzaat, Bram M., et al.
Publicado: (2017)

From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis
por: Araújo, Tiago, et al.
Publicado: (2021)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
por: Ekman, Diana, et al.
Publicado: (2023)

Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
por: McClure, Mark E, et al.
Publicado: (2020)

Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study
por: Ozaki, Shoichi, et al.
Publicado: (2011)

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
por: O'Sullivan, Kim M., et al.
Publicado: (2021)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
por: Harris, Claire, et al.
Publicado: (2018)

Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
por: Dahlqvist, Johanna, et al.
Publicado: (2021)

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review
por: Dikovec, Cédric, et al.
Publicado: (2022)

PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
por: Chen, Dhruti P., et al.
Publicado: (2023)

Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies
por: O’Brien, Eóin C., et al.
Publicado: (2015)

MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits
por: Matsumoto, Kei, et al.
Publicado: (2009)

PReS-FINAL-2311: Rituximab in paediatric ANCA-associated vasculitis
por: Mestrallet, G, et al.
Publicado: (2013)

Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab
por: Allinovi, Marco, et al.
Publicado: (2017)

Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange
por: Sagmeister, Michael S., et al.
Publicado: (2018)

Membranous Nephropathy With MPO-ANCA-Associated Crescentic GN
por: Kanodia, Kamal, et al.
Publicado: (2014)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

MPO-ANCA Rapidly Progressive Glomerulonephritis with Immune Deposits
por: Acosta, Eric, et al.
Publicado: (2022)

Posttransplant outcome of atypical haemolytic uraemic syndrome in a patient with thrombomodulin mutation: a case without recurrence
por: Caroti, Leonardo, et al.
Publicado: (2015)

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
por: Smith, Rona M, et al.
Publicado: (2023)

De novo collapsing glomerulopathy after kidney transplantation: Description of two cases
por: Cutruzzulà, Roberta, et al.
Publicado: (2023)

A Case Report Describing a Rare Presentation of Simultaneous Occurrence of MPO-ANCA-Associated Vasculitis and Rheumatoid Arthritis
por: Foray, Nathalie, et al.
Publicado: (2016)

The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review
por: Habibi, Mohammad Amin, et al.
Publicado: (2022)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract
por: Hasegawa, Jumpei, et al.
Publicado: (2018)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19
por: Uppal, Nupur N., et al.
Publicado: (2020)

Altered circulating CCR6(+)and CXCR3(+) T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
por: Liao, Zhonghua, et al.
Publicado: (2021)

The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis
por: Bai, Xue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_18k7qkgn4micvrm389jo3tivlu